Among patients with a moderately severe levels of depression (PHQ-9 score ≥ 15), 30.8% were diagnosed as having depression.
The score range was 1 7, where level 1 denotes severe dysphagia, level 2 moderately-severe dysphagia, level 3 moderate-dysphagia, level 4 mild-to-moderate dysphagia, level 5 mild-dysphagia, level 6 within functional limit/modified independence, and level 7 normal under all situations.
This scale can range from intact (level 0), borderline intact, mild, moderate, moderately severe and severe impairment to very severe impairment (level 6) [ 42].
Based on the PHQ-9/8 score cut points, depression is divided into multiple levels: mild, moderate, moderately severe, and severe [ 11].
Model 3 examined a dose response effect of depression across categories (moderate, moderately severe, and severe) relative to participants with none/mild levels of depressive symptoms adjusting for sociodemographics, cutaneous allodynia, SRPD-anxiety, and migraine pain intensity.
17 The time in each disease state (predementia, mild, moderate, moderately severe, or severe) was computed.
Scoring: 10 19 moderate (includes moderate and moderately severe) depression, 20 27 severe depression.
The baseline measures suggest that most of the women had moderate to moderately severe depression, as well as moderately high levels of anxiety.
Recruitment methods which focussed on community promotion effectively reached individuals with moderate to moderately severe depression (mean PHQ-9 score 14.5) and moderate levels of anxiety (mean GAD-7 score 12.0).
Summary scores range from 0 to 27, indicating depression levels of "none/minimal" (0 4), "mild" (5 9), "moderate" (10 14), "moderately severe" (15 19), or "severe" (> 19).
